Edwards Lifesciences Corp (NYSE:EW) climbed 11 percent after the company won a court ruling that limited the sale of Medtronic’s (MDT) CoreValve system in the US. Edwards Lifesciences Corp (NYSE:EW) stock performance was 11.00% in last session and finished the day at $81.00. Traded volume was 7.23million shares in the last session and the average volume of the stock remained 1.36million shares. The beta of … Continue reading Healthcare Unusual Volume: Edwards Lifesciences Corp (NYSE:EW), Allergan (NYSE:AGN), Akebia Therapeutics (NASDAQ:AKBA), Acorda Therapeutics (NASDAQ:ACOR)